Research map: Reduced-Dose OnabotulinumtoxinA for Urgency Incontinence in Older Women: Methods

Papers in this map

1. Prevalence of Symptomatic Pelvic Floor Disorders in US Women · Ingrid Nygaard · 2008 · 1876 citations · Cited by this paper
2. Age and Perioperative Outcomes Following Minimally Invasive Sacrocolpopexy · 2026 · Related
3. Validity and reliability of the Edmonton Frail Scale · Darryl B. Rolfson · 2006 · 1663 citations · Cited by this paper
4. Use of Spanish-Validated Patient-Reported Outcome Measures in Urogynecology · 2026 · Related
5. Short forms to assess life quality and symptom distress for urinary incontinence in women: The incontinence impact questionnaire and the urogenital distress inventory · John S. Uebersax · 1995 · 1437 citations · Cited by this paper
6. Laparoscopic Assistance Overestimates Resident Exposure to Vaginal Hysterectomy · 2026 · Related
7. Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory · Sally Ann Shumaker · 1994 · 1120 citations · Cited by this paper
8. Bridging the Gap in Sacrocolpopexy · 2026 · Related
9. Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment · Elizabeth Ann Gormley · 2015 · 793 citations · Cited by this paper
10. Cost-effectiveness of Total Versus Supracervical Hysterectomy at Sacrocolpopexy · 2026 · Related
11. Prevalence of Urinary Incontinence and Other Urological Symptoms in the Noninstitutionalized Elderly · Ananias C. Diokno · 1986 · 754 citations · Cited by this paper
12. Cost-effectiveness of Antibacterial Envelope for Sacral Neuromodulation Infection Prevention · 2026 · Related
13. Sample sizes for clinical trials with Normal data · Steven A. Julious · 2004 · 625 citations · Cited by this paper
14. Readability of Patient-Reported Outcome Measures in Urogynecology · 2026 · Related
15. Anticholinergic Drug Exposure and the Risk of Dementia · Carol A. C. Coupland · 2019 · 614 citations · Cited by this paper
16. Nocturnal Polyuria and MACE: Neuroendocrine Links Explaining Sex Differences · 2026 · Related
17. Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019 · Deborah J. Lightner · 2019 · 581 citations · Cited by this paper
18. Counseling After Obstetric Anal Sphincter Injury: How do Health Care Providers Perform? · 2026 · Related
19. Anticholinergic drugs and risk of dementia: case-control study · Kathryn Richardson · 2018 · 509 citations · Cited by this paper
20. Effect of Medicaid Expansion on Access to Pelvic Organ Prolapse Surgery · 2026 · Related
21. OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial · Christopher Reginald Chapple · 2013 · 415 citations · Cited by this paper
22. OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial · Victor W. Νitti · 2012 · 411 citations · Cited by this paper
23. SPIRIT 2025 statement: updated guideline for protocols of randomised trials · An‐Wen Chan · 2025 · 406 citations · Cited by this paper
24. Efficacy and Safety of OnabotulinumtoxinA for Idiopathic Overactive Bladder: A Double-Blind, Placebo Controlled, Randomized, Dose Ranging Trial · Roger Roman Dmochowski · 2010 · 405 citations · Cited by this paper
25. Medically recognized urinary incontinence and risks of hospitalization, nursing home admission and mortality · David H. Thom · 1997 · 368 citations · Cited by this paper
26. The Impact of Urinary Urgency and Frequency on Health-Related Quality of Life in Overactive Bladder: Results from a National Community Survey · Karin S. Coyne · 2004 · 354 citations · Cited by this paper
27. Improving recruitment of older people to research through good practice · Marion E. T. McMurdo · 2011 · 279 citations · Cited by this paper
28. Economic Costs of Overactive Bladder in the United States · Michael Lee Ganz · 2009 · 257 citations · Cited by this paper
29. OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women · Cindy L. Amundsen · 2016 · 233 citations · Cited by this paper
30. Anticholinergic Therapy vs. OnabotulinumtoxinA for Urgency Urinary Incontinence · Anthony G. Visco · 2012 · 225 citations · Cited by this paper
31. The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder · Anne Pelletier Cameron · 2024 · 207 citations · Cited by this paper
32. The iceberg of health care utilization in women with urinary incontinence · Vatche Arakel Minassian · 2012 · 180 citations · Cited by this paper
33. Efficacy and Safety of Low Doses of OnabotulinumtoxinA for the Treatment of Refractory Idiopathic Overactive Bladder: A Multicentre, Double-Blind, Randomised, Placebo-Controlled Dose-Ranging Study · P. Denys · 2011 · 164 citations · Cited by this paper
34. An overactive bladder symptom and health-related quality of life short-form: Validation of the OAB-q SF · Karin S. Coyne · 2014 · 161 citations · Cited by this paper
35. A framework for the analysis of heterogeneity of treatment effect in patient-centered outcomes research · Ravi Varadhan · 2013 · 152 citations · Cited by this paper
36. Two-Year Outcomes of Sacral Neuromodulation Versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: A Randomized Trial · Cindy L. Amundsen · 2018 · 143 citations · Cited by this paper
37. Determining the Importance of Change in the Overactive Bladder Questionnaire · Karin S. Coyne · 2006 · 142 citations · Cited by this paper
38. AUA White Paper on Nonneurogenic Chronic Urinary Retention: Consensus Definition, Treatment Algorithm, and Outcome End Points · John T. Stoffel · 2017 · 131 citations · Cited by this paper
39. Effect of clean intermittent self‐catheterization on quality of life: a qualitative study · Christopher R. Shaw · 2008 · 101 citations · Cited by this paper

Source: OpenAlex (CC0)